US6176962B1
(en)
|
1990-02-28 |
2001-01-23 |
Aclara Biosciences, Inc. |
Methods for fabricating enclosed microchannel structures
|
SE9002480D0
(sv)
|
1990-07-23 |
1990-07-23 |
Hans Lilja |
Assay of free and complexed prostate-specific antigen
|
EP0635575A1
(en)
|
1993-07-22 |
1995-01-25 |
Wallac Oy |
Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen
|
US5516639A
(en)
|
1993-07-22 |
1996-05-14 |
Mayo Foundation For Medical Education And Research |
Antibodies specific for human prostate glandular kallkrein
|
CA2175056A1
(en)
|
1993-10-28 |
1995-05-04 |
Imants R. Lauks |
Fluid sample collection and introduction device
|
US5599677A
(en)
|
1993-12-29 |
1997-02-04 |
Abbott Laboratories |
Immunoassays for prostate specific antigen
|
US5585069A
(en)
|
1994-11-10 |
1996-12-17 |
David Sarnoff Research Center, Inc. |
Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
|
US5614372A
(en)
|
1995-02-24 |
1997-03-25 |
Lilja; Hans |
Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
|
EP0843817A1
(en)
|
1995-08-03 |
1998-05-27 |
Akzo Nobel N.V. |
Diagnostic device
|
US6143509A
(en)
|
1996-02-06 |
2000-11-07 |
Abbott Laboratories |
Prostate specific antigen peptides and uses thereof
|
WO1997039351A1
(en)
|
1996-04-12 |
1997-10-23 |
Carter Herbert B |
Novel methods for the prediction and early detection of prostatic adenocarcinoma
|
US5840501A
(en)
|
1996-10-25 |
1998-11-24 |
Bayer Corporation |
Determination of cPSA
|
US5945289A
(en)
|
1996-12-20 |
1999-08-31 |
Lehrer; Steven |
Method for detecting prostate cancer by apolipoprotein E (Apo-E) genotyping
|
US5842787A
(en)
|
1997-10-09 |
1998-12-01 |
Caliper Technologies Corporation |
Microfluidic systems incorporating varied channel dimensions
|
SE9704934D0
(sv)
|
1997-12-30 |
1997-12-30 |
Pharmacia & Upjohn Diag Ab |
Analysförfarande med tillsättning i två eller flera positioner
|
FI980488A
(fi)
|
1998-03-04 |
1999-09-05 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
FR2780791B1
(fr)
|
1998-07-03 |
2000-09-01 |
Bio Merieux |
Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre
|
WO2000044940A2
(en)
|
1999-01-28 |
2000-08-03 |
Gen-Probe Incorporated |
Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
|
US6444425B1
(en)
|
1999-04-02 |
2002-09-03 |
Corixa Corporation |
Compounds for therapy and diagnosis of lung cancer and methods for their use
|
US7211397B2
(en)
|
1999-04-30 |
2007-05-01 |
Beckman Coulter, Inc. |
Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
|
US6136549A
(en)
|
1999-10-15 |
2000-10-24 |
Feistel; Christopher C. |
systems and methods for performing magnetic chromatography assays
|
FI20002127A0
(fi)
*
|
2000-09-27 |
2000-09-27 |
Artic Partners Oy Ab |
Uusi vasta-aine, immunomääritys ja menetelmä eturauhassyövän havaitsemiseksi
|
WO2002030562A1
(en)
|
2000-10-10 |
2002-04-18 |
Aviva Biosciences Corporation |
An integrated biochip system for sample preparation and analysis
|
ATE362107T1
(de)
|
2000-11-20 |
2007-06-15 |
Eastern Virginia Med School |
Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker
|
US20040219163A1
(en)
|
2001-10-03 |
2004-11-04 |
Frelinger John G. |
Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2
|
EP1461606A4
(en)
|
2001-12-05 |
2005-06-29 |
Univ Washington |
MICROFLUIDIC DEVICE AND SURFACE DECORATION METHOD FOR SOLID PHASE AFFINITY BINDING ASSAYS
|
US20030235816A1
(en)
|
2002-03-14 |
2003-12-25 |
Baylor College Of Medicine (By Slawin And Shariat) |
Method to determine outcome for patients with prostatic disease
|
US20050272052A1
(en)
|
2002-04-09 |
2005-12-08 |
Affymetrix, Inc. |
Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
|
AU2003242389A1
(en)
|
2002-05-28 |
2003-12-12 |
Jokoh Co., Ltd |
Immunological chromatograph method test slip reading/quantitative determination device
|
EP1540010B8
(en)
|
2002-08-06 |
2010-07-14 |
The Johns Hopkins University |
Use of biomarkers for detecting ovarian cancer
|
US20040115794A1
(en)
|
2002-12-12 |
2004-06-17 |
Affymetrix, Inc. |
Methods for detecting transcriptional factor binding sites
|
ES2427853T3
(es)
|
2003-02-07 |
2013-11-04 |
Diagnocure Inc. |
Procedimiento para detectar cáncer de próstata en una muestra
|
US7461048B2
(en)
|
2003-07-21 |
2008-12-02 |
Aureon Laboratories, Inc. |
Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
|
US20060269971A1
(en)
|
2003-09-26 |
2006-11-30 |
Mount Sinai Hospital |
Methods for detecting prostate cancer
|
EP1535667A1
(en)
|
2003-11-28 |
2005-06-01 |
Sysmex Corporation |
Analyzer, assay cartridge and analyzing method
|
WO2005056186A1
(en)
|
2003-12-10 |
2005-06-23 |
The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
A modular biochip assembly
|
EP1704405A1
(en)
|
2003-12-31 |
2006-09-27 |
The President and Fellows of Harvard College |
Assay device and method
|
US8030057B2
(en)
|
2004-01-26 |
2011-10-04 |
President And Fellows Of Harvard College |
Fluid delivery system and method
|
DK1776181T3
(da)
|
2004-01-26 |
2014-01-06 |
Harvard College |
System og fremgangsmåde til fluidtilførsel
|
TW200538734A
(en)
|
2004-03-12 |
2005-12-01 |
Aureon Biosciences Corp |
Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
|
WO2005111625A2
(en)
|
2004-05-11 |
2005-11-24 |
Baylor College Of Medicine |
Method to predict prostate cancer
|
US20060154276A1
(en)
|
2004-05-13 |
2006-07-13 |
Prometheus Laboratories Inc. |
Methods of diagnosing inflammatory bowel disease
|
EP1778856A4
(en)
|
2004-08-02 |
2008-05-28 |
Childrens Medical Center |
BLOOD BIOMARKER FOR CANCER
|
US7951529B2
(en)
|
2004-09-17 |
2011-05-31 |
The Johns Hopkins University |
Biomarkers for breast cancer
|
US8663600B2
(en)
|
2005-02-17 |
2014-03-04 |
Diaprost Ab |
Diagnosis of prostate cancer
|
WO2006122312A2
(en)
|
2005-05-11 |
2006-11-16 |
The Trustees Of The University Of Pennsylvania |
Methods of testing using a microfluidic cassette
|
US20070065954A1
(en)
|
2005-09-15 |
2007-03-22 |
Minoru Taya |
Surface plasmon resonance biosensor system for detection of antigens and method for determining the presence of antigens
|
KR20090006837A
(ko)
|
2006-03-24 |
2009-01-15 |
페노미넘 디스커버리스 인코포레이티드 |
전립선 암 진단용 생물표지자 및 그의 제조방법
|
EP2044216A2
(en)
|
2006-07-03 |
2009-04-08 |
Exonhit Therapeutics SA |
Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
|
CN1973778A
(zh)
|
2006-12-08 |
2007-06-06 |
南京大学 |
胃癌术后严重并发症风险度的预测方法
|
JP5523108B2
(ja)
|
2006-12-22 |
2014-06-18 |
ファディア・アクチボラグ |
新規アレルゲンとしての前立腺カリクレイン
|
EP2152417B1
(en)
|
2007-05-04 |
2018-07-11 |
Opko Diagnostics, LLC |
Device and method for analyses in microfluidic systems
|
CN101918836B
(zh)
|
2007-05-08 |
2014-04-30 |
皮可贝拉有限责任公司 |
诊断和治疗前列腺癌和肺癌的方法
|
CN101329343A
(zh)
|
2007-06-19 |
2008-12-24 |
天津迪爱盟生物技术有限公司 |
新一代早期诊断前列腺癌试剂盒及其制备方法和检测方法
|
WO2009029550A2
(en)
*
|
2007-08-24 |
2009-03-05 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of prostate specific antigen (psa)
|
CN101377500A
(zh)
*
|
2007-08-31 |
2009-03-04 |
北京科美东雅生物技术有限公司 |
游离前列腺特异性抗原化学发光免疫分析测定试剂盒及其制备方法
|
ES2543985T3
(es)
|
2007-10-22 |
2015-08-26 |
St Vincent's Hospital Sydney Limited |
Métodos de pronóstico
|
US20090226912A1
(en)
|
2007-12-21 |
2009-09-10 |
Wake Forest University Health Sciences |
Methods and compositions for correlating genetic markers with prostate cancer risk
|
JP5028697B2
(ja)
|
2008-02-18 |
2012-09-19 |
富士フイルム株式会社 |
吸引シリンジ及び内視鏡用吸引シリンジ
|
JP2011521215A
(ja)
|
2008-05-14 |
2011-07-21 |
エーテーハー チューリヒ |
前立腺癌の診断及び治療のためのバイオマーカー及び薬剤標的発見法、並びにそれを用いて決定されるバイオマーカーアッセイ
|
FR2934698B1
(fr)
|
2008-08-01 |
2011-11-18 |
Commissariat Energie Atomique |
Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.
|
KR20110086074A
(ko)
|
2008-10-20 |
2011-07-27 |
리포사이언스, 인크. |
지질단백질 인슐린 저항성 지표 및 이와 관련된 방법, 시스템 및 이를 생성하기 위한 컴퓨터 프로그램
|
US20110236903A1
(en)
|
2008-12-04 |
2011-09-29 |
Mcclelland Michael |
Materials and methods for determining diagnosis and prognosis of prostate cancer
|
EP2376226B1
(en)
|
2008-12-18 |
2018-09-12 |
Opko Diagnostics, LLC |
Improved reagent storage in microfluidic systems and related articles and methods
|
US20100168621A1
(en)
|
2008-12-23 |
2010-07-01 |
Neville Thomas B |
Methods and systems for prostate health monitoring
|
US20120022793A1
(en)
|
2009-01-19 |
2012-01-26 |
Miraculins, Inc. |
Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population
|
EP2391451B1
(en)
|
2009-02-02 |
2018-09-12 |
Opko Diagnostics, LLC |
Structures for controlling light interaction with microfluidic devices
|
JP2010243406A
(ja)
|
2009-04-08 |
2010-10-28 |
F Hoffmann La Roche Ag |
Afpおよびpivka−iiの測定値を特徴値とした識別関数を利用する、肝臓癌および慢性肝疾患の病態進行度の検出方法
|
NZ596054A
(en)
|
2009-05-01 |
2013-07-26 |
Genomic Health Inc |
Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
|
DE112010002253T5
(de)
|
2009-06-04 |
2013-01-03 |
Charité - Universitätsmedizin Berlin |
Mittel und Verfahren zur Diagnostizierung von Prostatakarzinomen
|
WO2011027308A1
(en)
|
2009-09-03 |
2011-03-10 |
Koninklijke Philips Electronics N.V. |
Novel tumor markers
|
WO2011027310A1
(en)
|
2009-09-03 |
2011-03-10 |
Koninklijke Philips Electronics N.V. |
Novel tumor markers
|
KR101141190B1
(ko)
|
2009-10-19 |
2012-06-13 |
중앙대학교 산학협력단 |
전립선암에 대한 바이오마커 및 이를 이용한 전립선암 진단
|
CN105218674A
(zh)
|
2010-03-11 |
2016-01-06 |
瑞纳神经科学公司 |
呈pH依赖性抗原结合的抗体
|
JP6204190B2
(ja)
|
2010-04-16 |
2017-09-27 |
オプコ・ダイアグノスティクス・リミテッド・ライアビリティ・カンパニーOpko Diagnostics,Llc |
試料の分析のためのシステムおよびデバイス
|
WO2012029080A1
(en)
|
2010-08-30 |
2012-03-08 |
Decode Genetics Ehf |
Sequence variants associated with prostate specific antigen levels
|
BRPI1100857A2
(pt)
|
2011-03-18 |
2013-05-21 |
Alexandre Eduardo Nowill |
agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
|
WO2012129408A2
(en)
|
2011-03-22 |
2012-09-27 |
The Johns Hopkins University |
Biomarkers for aggressive prostate cancer
|
WO2012170776A2
(en)
*
|
2011-06-09 |
2012-12-13 |
Quanterix Corporation |
Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy
|
US9638706B2
(en)
|
2011-07-21 |
2017-05-02 |
Wako Pure Chemical Industries, Ltd. |
Standard solution for use in analysis of amino acid in plasma
|
KR102232811B1
(ko)
|
2011-10-28 |
2021-03-29 |
프레닥스 에이비 |
치료제 및 이의 용도
|
WO2013106778A2
(en)
*
|
2012-01-13 |
2013-07-18 |
Iris International, Inc. |
Non-equilibrium two-site assays for linear, ultrasensitive analyte detection
|
PL2823427T3
(pl)
|
2012-03-05 |
2021-07-12 |
Oy Arctic Partners Ab |
Systemy komputerowe, sposoby i odczytywalne komputerowo nośniki danych do przewidywania ryzyka objętości gruczołu krokowego
|
WO2013172779A2
(en)
*
|
2012-05-16 |
2013-11-21 |
Phadia Ab |
Method for indicating the presence or non-presence of prostate cancer
|
CA2877721A1
(en)
|
2012-06-27 |
2014-01-03 |
Berg Llc |
Use of markers in the diagnosis and treatment of prostate cancer
|
CN102818892B
(zh)
|
2012-08-16 |
2015-02-18 |
北京恩济和生物科技有限公司 |
一种前列腺特异性抗原检测试剂盒及其制备方法
|
US9175291B2
(en)
|
2012-10-11 |
2015-11-03 |
Isis Pharmaceuticals Inc. |
Modulation of androgen receptor expression
|
ES2694409T3
(es)
|
2012-11-20 |
2018-12-20 |
Phadia Ab |
Método de pronóstico para individuos con cáncer de próstata
|
CA3092807C
(en)
|
2012-11-20 |
2024-02-27 |
Phadia Ab |
Method for indicating a presence or non-presence of aggressive prostate cancer
|
CN112898431A
(zh)
|
2013-11-19 |
2021-06-04 |
弗雷达克斯有限责任公司 |
人源化抗激肽释放酶-2抗体
|
CA3134289A1
(en)
|
2014-03-11 |
2015-09-17 |
Phadia Ab |
Method for detecting a solid tumor cancer
|
US20170089904A1
(en)
|
2014-03-28 |
2017-03-30 |
Opko Diagnostics, Llc |
Compositions and methods for active surveillance of prostate cancer
|
CN106663149A
(zh)
|
2014-03-28 |
2017-05-10 |
欧普科诊断有限责任公司 |
与前列腺癌的诊断有关的组合物和方法
|
EP3268978A1
(en)
|
2015-03-12 |
2018-01-17 |
Thermo Finnigan LLC |
Methods for data-dependent mass spectrometry of mixed biomolecular analytes
|
EA039028B1
(ru)
|
2015-04-29 |
2021-11-24 |
Опкоу Дайагностикс, Ллк |
Способ, компьютер и система для определения вероятности события, ассоциированного с раком предстательной железы
|
US20190072555A1
(en)
|
2017-08-14 |
2019-03-07 |
Opko Diagnostics, Llc |
Multiplex assays for evaluating prostate cancer status
|
WO2019221930A1
(en)
|
2018-05-16 |
2019-11-21 |
Opko Diagnostics, Llc |
Methods for detecting prostate cancer pathology associated with adverse outcomes
|